drugset / Trial / NCT00657449
A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain
RandomizedParallel-groupDouble-blindTreatment
Summary
The study compares valdecoxib 40 mg once daily vs. rofecoxib 50 mg one daily in treating the signs and symptoms of acute first- or second-degree ankle sprain. The study also evaluated the disability status, tolerability and safety of these treatments.
Timeline
- Start
- 2003-06-04
- Primary completion
- 2004-10-01
- Completion
- 2004-10-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | rofecoxib | Small molecule | 50 mg | Oral |
| Comparator | valdecoxib | Small molecule | 40 mg | Oral |
Indications
No indication recorded.